Daniel P. Andersson

2.6k total citations
63 papers, 1.9k citations indexed

About

Daniel P. Andersson is a scholar working on Physiology, Epidemiology and Surgery. According to data from OpenAlex, Daniel P. Andersson has authored 63 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 23 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Daniel P. Andersson's work include Adipose Tissue and Metabolism (24 papers), Adipokines, Inflammation, and Metabolic Diseases (19 papers) and Bariatric Surgery and Outcomes (15 papers). Daniel P. Andersson is often cited by papers focused on Adipose Tissue and Metabolism (24 papers), Adipokines, Inflammation, and Metabolic Diseases (19 papers) and Bariatric Surgery and Outcomes (15 papers). Daniel P. Andersson collaborates with scholars based in Sweden, Denmark and France. Daniel P. Andersson's co-authors include Peter Arner, Mikael Rydén, Anders Thorell, Jesper Bäckdahl, Ingrid Dahlman, Johan Hoffstedt, Jurga Laurencikiene, Patrik Löfgren, Erik Näslund and Mikael Wirén and has published in prestigious journals such as Cell, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Daniel P. Andersson

58 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel P. Andersson Sweden 23 1.1k 765 498 429 299 63 1.9k
Michael M. Swarbrick Australia 28 1.8k 1.7× 1.0k 1.3× 417 0.8× 708 1.7× 448 1.5× 41 2.9k
Pierre‐Henri Ducluzeau France 26 502 0.5× 433 0.6× 251 0.5× 682 1.6× 237 0.8× 49 1.8k
Pauli Karhapää Finland 26 477 0.4× 539 0.7× 307 0.6× 328 0.8× 433 1.4× 38 2.1k
Lenka Rossmeislová Czechia 19 851 0.8× 409 0.5× 149 0.3× 403 0.9× 140 0.5× 41 1.4k
Susanne Greber‐Platzer Austria 21 378 0.3× 301 0.4× 152 0.3× 254 0.6× 366 1.2× 90 1.4k
Chee Eng Tan Singapore 19 315 0.3× 291 0.4× 308 0.6× 296 0.7× 261 0.9× 25 1.4k
Eleonora Santini Italy 18 290 0.3× 287 0.4× 261 0.5× 372 0.9× 215 0.7× 34 1.3k
Simon Biron Canada 33 1.3k 1.2× 450 0.6× 384 0.8× 432 1.0× 1.9k 6.4× 71 3.3k
Monica D’Adamo Italy 20 508 0.5× 310 0.4× 186 0.4× 373 0.9× 244 0.8× 40 1.2k
Georgios K. Dimitriadis United Kingdom 22 364 0.3× 354 0.5× 190 0.4× 323 0.8× 469 1.6× 100 1.7k

Countries citing papers authored by Daniel P. Andersson

Since Specialization
Citations

This map shows the geographic impact of Daniel P. Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Andersson more than expected).

Fields of papers citing papers by Daniel P. Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Andersson. The network helps show where Daniel P. Andersson may publish in the future.

Co-authorship network of co-authors of Daniel P. Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Andersson. A scholar is included among the top collaborators of Daniel P. Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Andersson. Daniel P. Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, Daniel P., et al.. (2026). Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. Journal of Internal Medicine. 299(4). 481–501.
2.
Mossberg, Karin, Erin C. Standen, Jocelyn Lebow, et al.. (2025). Integrative Strategies in Primary Care: Addressing Recurrent Weight Gain Post‐Metabolic and Bariatric Surgery. Obesity Science & Practice. 11(4). e70087–e70087.
3.
Arner, Peter, Thorkild I. A. Sørensen, & Daniel P. Andersson. (2025). Adipose cellularity as a measurement of long-term changes in body weight: a Swedish cohort study spanning 1988–2016. EClinicalMedicine. 82. 103165–103165.
4.
Massier, Lucas, Daniel P. Andersson, Nathalie Viguerie, et al.. (2025). The nature of sex differences in catecholamine-induced lipolysis in subcutaneous fat cells. iScience. 28(12). 113988–113988.
5.
Stocks, Ben, John Henderson, David Rizo‐Roca, et al.. (2025). Personalized molecular signatures of insulin resistance and type 2 diabetes. Cell. 188(15). 4106–4122.e16. 4 indexed citations
6.
Yu, Lei, Anna Wiik, Margery A. Connelly, et al.. (2024). Cardiometabolic Risk Assessment in Transgender Individuals—Differential Effect of Sex Hormones and Sex Chromosomes. The Journal of Clinical Endocrinology & Metabolism. 110(7). e2273–e2284.
7.
Subramanian, N, Anna Wiik, Eric Rullman, et al.. (2024). Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals. Journal of Endocrinological Investigation. 47(9). 2249–2260. 3 indexed citations
8.
Lagerros, Ylva Trolle, et al.. (2024). Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors. Journal of the American College of Cardiology. 83(3). 417–426. 4 indexed citations
9.
Kerr, Alastair G., Daniel P. Andersson, Mikael Rydén, & Peter Arner. (2023). Insulin resistance in adipocytes: Novel insights into the pathophysiology of metabolic syndrome. Clinical Nutrition. 43(2). 468–475. 8 indexed citations
10.
Subramanian, N, Beatriz Tavira, Lucas Massier, et al.. (2023). Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells. Cardiovascular Diabetology. 22(1). 84–84. 2 indexed citations
11.
Jernberg, Tomas, Göran Bergström, Anders Blomberg, et al.. (2021). Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19: population-based cohort study in Sweden (SCAPIS). BMJ Open. 11(9). e051359–e051359. 9 indexed citations
12.
Kwok, Kelvin H. M., Daniel P. Andersson, Mikael Rydén, & Peter Arner. (2021). A longitudinal study of the antilipolytic effect of insulin in women following bariatric surgery. International Journal of Obesity. 45(12). 2675–2678. 5 indexed citations
13.
Andersson, Daniel P., Ylva Trolle Lagerros, Alessandra Grotta, et al.. (2021). Association of Phosphodiesterase-5 Inhibitors Versus Alprostadil With Survival in Men With Coronary Artery Disease. Journal of the American College of Cardiology. 77(12). 1535–1550. 21 indexed citations
14.
Arner, Peter, Samuel Bernard, Kai‐Yun Fu, et al.. (2019). Adipose lipid turnover and long-term changes in body weight. Nature Medicine. 25(9). 1385–1389. 100 indexed citations
15.
Rydén, Mikael, Daniel P. Andersson, Gallic Beauchef, et al.. (2019). Prospective analyses of white adipose tissue gene expression in relation to long-term body weight changes. International Journal of Obesity. 44(2). 377–387. 12 indexed citations
16.
Andersson, Daniel P., Ylva Trolle Lagerros, Alessandra Grotta, et al.. (2017). ASSOCIATION BETWEEN ERECTILE DYSFUNCTION AND DEATH OR CARDIOVASCULAR OUTCOMES AFTER MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 69(11). 136–136. 1 indexed citations
17.
Andersson, Daniel P., et al.. (2017). Abdominal subcutaneous adipose tissue cellularity in men and women. International Journal of Obesity. 41(10). 1564–1569. 34 indexed citations
18.
Andersson, Daniel P., Jurga Laurencikiene, Juan R. Acosta, Mikael Rydén, & Peter Arner. (2016). Circulating and Adipose Levels of Adipokines Associated With Insulin Sensitivity in Nonobese Subjects With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 101(10). 3765–3771. 22 indexed citations
19.
Dahlman, Ingrid, Indranil Sinha, Hui Gao, et al.. (2015). The fat cell epigenetic signature in post-obese women is characterized by global hypomethylation and differential DNA methylation of adipogenesis genes. International Journal of Obesity. 39(6). 910–919. 76 indexed citations
20.
Acosta, Juan R., Iyadh Douagi, Daniel P. Andersson, et al.. (2015). Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia. 59(3). 560–570. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026